The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2018 | Key updates in therapies for acute leukemias from ASH 2018
Daniel DeAngelo
• 6 Dec 2018
Daniel DeAngelo, MD, PhD, of the Dana-Farber Cancer Institute, Boston, MA, gives his take on the highlights for acute leukemia from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA.
